Advent Pharma Ltd. (DSE:ADVENT)

Bangladesh · Delayed Price · Currency is BDT

13.30

+0.30 (2.31%)

At close: Nov 4, 2026

Market Cap	1.24B -8.3%
Revenue (ttm)	458.15M -4.3%
Net Income	48.03M -1.3%
EPS	0.52 -0.7%
Shares Out	93.13M
PE Ratio	25.63
Forward PE	n/a
Dividend	0.05 (0.38%)
Ex-Dividend Date	Nov 23, 2026

Volume	93,184
Open	n/a
Previous Close	13.00
Day's Range	13.00 - 13.40
52-Week Range	11.50 - 17.10
Beta	0.27
Analysts	n/a
Price Target	n/a
Est. Earnings	Nov 9, 2026

About Advent Pharma

Advent Pharma Ltd., a pharmaceutical company, manufactures, imports, and markets animal health care drugs, nutritional supplements, and feed additives for livestock in Bangladesh. The company offers poultry, aquaculture, and cattle products. It provides its products in powder, bolus, and liquid dosage forms. It offers Yea-Sacc Bolus, Bioplex Dairy Max Bolus, SUPERIOR SYN BIOTECH, Oxi-D Bolus, and TOXOSORB. Advent Pharma Ltd. was incorporated in 2007 and is based in Dhaka, Bangladesh. [Read more]

Industry Pharmaceutical Preparations

Founded 2007

Employees 317

Stock Exchange Dhaka Stock Exchange

Ticker Symbol ADVENT

Full Company Profile

Financial Performance

In fiscal year 2025, Advent Pharma's revenue was 500.49 million, a decrease of -12.45% compared to the previous year's 571.67 million. Earnings were 66.87 million, a decrease of -20.38%.

Financial Statements